US EditionRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update
Summary by modernreaders.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
com-unik.infoReposted by 
modernreaders.com
modernreaders.comRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Short Interest Update
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 2,570,000 shares, a growth of 16.8% from the February 13th total of 2,200,000 shares. Approximately 2.5% of the company’s shares are sold short. […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
